“"However, it's important that these findings aren't interpreted as placing environmental responsibility on people living with obesity, or suggesting that medication is an environmental solution. The environmental impacts of what we eat are shaped by the wider food system, not simply by individual choices."
Weight Loss Drugs Could Offer Environmental Benefits, Study Suggests
New research from Scottish universities indicates widespread use of obesity medications may reduce global food demand and land use.
By Kirsty Lennox
••2 min read
AI
Generic image of abstract health and environmental concepts.
New research from the University of Aberdeen, in collaboration with the University of Edinburgh and Scotland’s Rural College (SRUC), suggests that widespread use of weight loss medications like Ozempic and Mounjaro could offer significant environmental benefits alongside health improvements.
The study, published in Nature Communications, investigated the potential impact of GLP-1 medications on global food demand, prices, trade, agricultural land use, and mortality. In the most ambitious scenarios, widespread GLP-1 use could lead to up to 6.6 million fewer global deaths by 2050 and free up approximately 32 million hectares of land from agriculture and managed forestry.
If these treatments were combined with healthier diets, the potential benefits could increase further, with an estimated 7.7 million fewer deaths and around 46 million hectares more land available. Dr Roslyn Henry from the University of Aberdeen, who led the study, stated that these changes in food consumption could have consequences beyond individual patients, potentially reducing pressure on natural land globally.
Dr Henry also highlighted the importance of supporting healthier diets alongside treatment, which requires both targeted guidance for GLP-1 users and broader policies to make healthy, sustainable diets more accessible and affordable for everyone.
Professor Peter Alexander of the University of Edinburgh, a co-author, added that food choices have consequences beyond personal health, influencing farmers' production, international trade, and land requirements. He emphasised the need to understand how the uptake of appetite-suppressing treatments could reshape food systems and their resulting environmental and health outcomes.
This research serves as an initial exploratory assessment of the potential food-system impacts of widespread GLP-1 medication use, rather than a forecast of future treatment trends or a recommendation for universal treatment. Future work may explore alternative assumptions regarding adherence, treatment duration, dietary changes, and weight regain as treatment options evolve.
Based on information from the official source: University of Aberdeen (19/11/2026)



